A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery (Q44413970)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 1, 2003

Language	Label	Description	Also known as
English	A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery	scientific article published on May 1, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

Lung cancer surgery

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0169-5002(03)00032-1

https://api.crossref.org/works/10.1016/S0169-5002(03)00032-1

27 December 2023

author name string

Chiaki Endo

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Yasuki Saito

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Hiroshi Iwanami

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Takao Tsushima

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tadashi Imai

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mitsuo Kawamura

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Takashi Kondo

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kaoru Koike

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Masashi Handa

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ryuzo Kanno

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shigefumi Fujimura

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

North-east Japan Study Group for Lung Cancer Surgery

12

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711119

27 December 2023

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0169500203000321?httpAccept=text/xml

1 reference

10.1016/S0169-5002(03)00032-1

https://api.crossref.org/works/10.1016/S0169-5002(03)00032-1

27 December 2023

https://api.elsevier.com/content/article/PII:S0169500203000321?httpAccept=text/plain

1 reference

10.1016/S0169-5002(03)00032-1

https://api.crossref.org/works/10.1016/S0169-5002(03)00032-1

27 December 2023

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

181-186

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant therapy for stage II non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(03)00032-1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44413970&oldid=2037944930"